✦ LIBER ✦

A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy

✍ Scribed by Whitney A. Spannuth; Charles A. Leath III; Warner K. Huh; Mack N. Barnes III; Susan A. Davidson; Larry C. Kilgore; Edward E. Partridge; J. Maxwell Austin Jr.; Ronald D. Alvarez

Book ID: 113960833
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 124 KB
Volume: 104
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2006.09.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II, multicenter trial of weekly

A phase II, multicenter trial of weekly topotecan in patients with recurrent platinum-sensitive epithelial cancers of the ovary and peritoneum

✍ J.V. BROWN III; M.A. RETTENMAIER; K.L. LOPEZ; C. GRAHAM; J.P. MICHA; B. GOLDSTEI 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Gemcitabine and oxaliplatin followed by

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

✍ C.B. Steer; K. Chrystal; K.A. Cheong; E. Galani; G.M. Marx; A.H. Strickland; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB